Century Therapeutics (IPSC) Assets Average (2021 - 2026)

Century Therapeutics (IPSC) has 6 years of Assets Average data on file, last reported at $275.1 million in Q1 2026.

• On a quarterly basis, Assets Average fell 17.73% year-over-year to $275.1 million in Q1 2026; TTM through Mar 2026 was $275.1 million, a 17.73% decrease from a year earlier, with the FY2025 full-year figure at $288.5 million, down 19.19% from the prior year.
• Assets Average for Q1 2026 stood at $275.1 million, up from $234.2 million in the prior quarter.
• Over the last five years, Assets Average for IPSC reached as high as $541.4 million in Q2 2022 and fell as low as $234.2 million in Q4 2025.
• Historically, Assets Average has averaged $392.4 million across 5 years, with a median of $382.5 million in 2024.
• Across the five-year window, Assets Average rose 10.05% in 2022 and plunged 36.86% in 2025, its largest moves.
• Year by year, Assets Average stood at $499.1 million in 2022, then decreased by 24.05% to $379.1 million in 2023, then fell by 2.16% to $370.9 million in 2024, then plunged by 36.86% to $234.2 million in 2025, then grew by 17.47% to $275.1 million in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $275.1 million in Q1 2026, $234.2 million in Q4 2025, and $264.7 million in Q3 2025.